Bionime Corporation (4737)
Market Closed
15 Jun, 05:30
TWSE TWSE Primary NT$
54. 90
0
0%
NT$
4.58B Market Cap
- P/E Ratio
8% Div Yield
41,832 Volume
- Eps
NT$ 54.9
Previous Close Want to track 4737 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
4737 closed today higher at NT$54.9, an increase of 0% from yesterday's close, completing a monthly decrease of -0.7233% or -NT$0.4. Over the past 12 months, 4737 stock lost -6.8386%.
4737 is not paying dividends to its shareholders.
The last earnings report, released on Mar 11, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0233%, based on the last three reports.
Bionime Corporation has completed 3 stock splits, with the recent split occurring on Sep 08, 2025.
The company's stock is traded on one exchange.
Bionime Corporation (4737) FAQ
What is the stock price today?
The current price is NT$54.90.
On which exchange is it traded?
Bionime Corporation is listed on TWSE.
What is its stock symbol?
The ticker symbol is 4737.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 8%.
What is its market cap?
As of today, the market cap is 4.58B.
Has Bionime Corporation ever had a stock split?
Bionime Corporation had 3 splits and the recent split was on Sep 08, 2025.
Bionime Corporation Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Mr. Chun-Mu Huang CEO | TWSE Exchange | TW0004737002 ISIN |
| TW Country | - Employees | 24 Jul 2023 Last Dividend | 20 Nov 2014 Last Split | - IPO Date |
Overview
Bionime Corporation specializes in designing, manufacturing, and distributing medical instruments across a broad geographic landscape that includes China, Switzerland, the United States, Algeria, Egypt, among other international markets. Founded in 2003 and headquartered in Taichung, Taiwan, the company plays a pivotal role in innovating healthcare solutions. Notably, Bionime also extends its expertise into biotechnology services, examines pharmaceuticals, and sells precision instruments, thereby encompassing a wide spectrum of healthcare and scientific needs.
Products and Services
- Blood Glucose Monitors: These devices are crucial for individuals with diabetes, enabling them to monitor their blood glucose levels regularly. Bionime Corporation offers advanced monitors that are known for their accuracy and ease of use, catering to both hospital and home settings.
- Self-Monitoring Devices: Beyond blood glucose monitoring, the company provides devices that empower patients to manage their health proactively. These include a range of self-monitoring tools designed for user-friendly, at-home health management.
- Accessories:
- Test Strips: Essential for the operation of blood glucose monitors, these strips allow for the measurement of blood glucose levels. They are designed for accuracy and compatibility with Bionime's monitoring devices.
- Lancing Devices: These devices are used to obtain blood samples for glucose testing. Bionime's lancing devices are engineered for minimal discomfort and usability, ensuring a better patient experience.
- Biotechnology Services: Bionime is not only a product-based company but also offers comprehensive biotechnology services. These services span from research and development in biotechnological fields to support in pharmaceutical examination and quality control, highlighting the company's versatile expertise in the biotech sector.
- Precision Instruments: Beyond healthcare, Bionime Corporation is involved in selling precision instruments. These are critical in various scientific and industrial applications that require high accuracy, demonstrating the company's commitment to innovation and quality across different domains.
Contact Information
Address: No. 100, Daqing Street, Taichung, Taiwan, 40242
Phone: 886 4 2369 2388
Website: https://www.bionime.com
